APA (7th ed.) Citation

Ghazi, N. G., Kirk, T. Q., Knape, R. M., & al, e. (2010). Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration? Dove Medical Press.

Chicago Style (17th ed.) Citation

Ghazi, Nicola G., Tyler Q. Kirk, Robert M. Knape, and et al. Is Monthly Retreatment with Intravitreal Bevacizumab (Avastin®) Necessary in Neovascular Age-related Macular Degeneration? Dove Medical Press, 2010.

MLA (8th ed.) Citation

Ghazi, Nicola G., et al. Is Monthly Retreatment with Intravitreal Bevacizumab (Avastin®) Necessary in Neovascular Age-related Macular Degeneration? Dove Medical Press, 2010.